Serum DKK1 is correlated with γ peak of serum electrophoresis in multiple myeloma: a multicenter biomarker study

Biomark Med. 2019 Oct;13(15):1297-1306. doi: 10.2217/bmm-2019-0060. Epub 2019 Oct 9.

Abstract

Aim: DKK1 is reported to be produced at high levels by myeloma cells. Therefore, the applicability of DKK1 as a tumor marker for multiple myeloma (MM) diagnosis was examined. Methods: Serum samples were collected and analyzed by DKK1 concentration kit and capillary zone electrophoresis. Then, the obtained results were statically analyzed. Results: It has been determined that the 10 ng/ml of DKK1 is the optimal level for MM diagnosis. Moreover, there was an ascending linear correlation between the DKK1 concentration and γ peak. Discussion: The observed correlation could be rooted in the positive feedback loop between MM cells and the mesenchymal stem cells. In view of these results, DKK1 could be deemed as diagnostic marker for MM.

Keywords: Bence Jones proteins; DKK1; ELISA; M protein; Wnt signaling; bone disease; diagnosis; mesenchymal stem cells; multiple myeloma; serum protein electrophoresis.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor / blood*
  • Electrophoresis, Capillary*
  • Female
  • Humans
  • Intercellular Signaling Peptides and Proteins / blood*
  • Male
  • Mesenchymal Stem Cells / pathology
  • Middle Aged
  • Multiple Myeloma / blood*
  • Multiple Myeloma / diagnosis
  • Multiple Myeloma / pathology

Substances

  • Biomarkers, Tumor
  • DKK1 protein, human
  • Intercellular Signaling Peptides and Proteins